Cardiometabolic Health Congress

NOVEMBER 14, 2024

cardiometabolic health CME/CE conference: the 19th Annual CMHC. 42% of adults are considered obese , increasing their risk of diabetes, hypertension, and cardiovascular issues. Biomarker-Based HF Prediction: Combined biomarker and imaging assessments provide the highest accuracy in predicting heart failure risk.

CME 103

CME Obesity Heart Failure Biomarkers 103

Cardiometabolic Health Congress

OCTOBER 25, 2024

The 19th Annual CMHC was more than just CME/CE medical education—it ignited global collaboration and inspired groundbreaking innovations. Attendees dove into cutting-edge topics, including FDA updates, resistant hypertension, and cardiac biomarkers. “I Aronne, MD , discussed advances in obesity pharmacology, while Virend K.

CME 64

CME Innovation Education Atherosclerosis 64

Cardiometabolic Health Congress

JULY 25, 2024

Innovations in Cardiorenal Metabolic Medicine The event will focus on the whole spectrum of cardiorenal metabolic disease, including obesity, diabetes, lipids, hypertension, and cardiorenal disease. The robust conference agenda begins with FDA updates and advancements in cardiorenal metabolic care.

Education 98

Education Innovation Risk Factors Obesity 98